TY - JOUR
T1 - Whole-exome sequencing identifies genes associated with Tourette’s disorder in multiplex families
AU - Tourette International Collaborative Genetics Study (TIC Genetics)
AU - Cao, Xiaolong
AU - Zhang, Yeting
AU - Abdulkadir, Mohamed
AU - Deng, Li
AU - Fernandez, Thomas V.
AU - Garcia-Delgar, Blanca
AU - Hagstrøm, Julie
AU - Hoekstra, Pieter J.
AU - King, Robert A.
AU - Koesterich, Justin
AU - Kuperman, Samuel
AU - Morer, Astrid
AU - Nasello, Cara
AU - Plessen, Kerstin J.
AU - Thackray, Joshua K.
AU - Zhou, Lisheng
AU - Brown, Lawrence W.
AU - Cao, Xiaolong
AU - Coffey, Barbara J.
AU - Gilbert, Donald L.
AU - Hedderly, Tammy
AU - Heyman, Isobel
AU - Huyser, Chaim
AU - Kim, Eunjoo
AU - Kim, Young Shin
AU - Koh, Yun Joo
AU - Leventhal, Bennett L.
AU - Madruga-Garrido, Marcos
AU - Maras, Athanasios
AU - Mir, Pablo
AU - Münchau, Alexander
AU - Roessner, Veit
AU - Song, Dong Ho
AU - State, Matthew W.
AU - Willsey, A. Jeremy
AU - Zinner, Samuel H.
AU - Dietrich, Andrea
AU - Tischfield, Jay A.
AU - Heiman, Gary A.
AU - Xing, Jinchuan
N1 - Publisher Copyright:
© 2021, The Author(s), under exclusive licence to Springer Nature Limited.
PY - 2021/11
Y1 - 2021/11
N2 - Tourette’s Disorder (TD) is a neurodevelopmental disorder (NDD) that affects about 0.7% of the population and is one of the most heritable NDDs. Nevertheless, because of its polygenic nature and genetic heterogeneity, the genetic etiology of TD is not well understood. In this study, we combined the segregation information in 13 TD multiplex families with high-throughput sequencing and genotyping to identify genes associated with TD. Using whole-exome sequencing and genotyping array data, we identified both small and large genetic variants within the individuals. We then combined multiple types of evidence to prioritize candidate genes for TD, including variant segregation pattern, variant function prediction, candidate gene expression, protein–protein interaction network, candidate genes from previous studies, etc. From the 13 families, 71 strong candidate genes were identified, including both known genes for NDDs and novel genes, such as HtrA Serine Peptidase 3 (HTRA3), Cadherin-Related Family Member 1 (CDHR1), and Zinc Finger DHHC-Type Palmitoyltransferase 17 (ZDHHC17). The candidate genes are enriched in several Gene Ontology categories, such as dynein complex and synaptic membrane. Candidate genes and pathways identified in this study provide biological insight into TD etiology and potential targets for future studies.
AB - Tourette’s Disorder (TD) is a neurodevelopmental disorder (NDD) that affects about 0.7% of the population and is one of the most heritable NDDs. Nevertheless, because of its polygenic nature and genetic heterogeneity, the genetic etiology of TD is not well understood. In this study, we combined the segregation information in 13 TD multiplex families with high-throughput sequencing and genotyping to identify genes associated with TD. Using whole-exome sequencing and genotyping array data, we identified both small and large genetic variants within the individuals. We then combined multiple types of evidence to prioritize candidate genes for TD, including variant segregation pattern, variant function prediction, candidate gene expression, protein–protein interaction network, candidate genes from previous studies, etc. From the 13 families, 71 strong candidate genes were identified, including both known genes for NDDs and novel genes, such as HtrA Serine Peptidase 3 (HTRA3), Cadherin-Related Family Member 1 (CDHR1), and Zinc Finger DHHC-Type Palmitoyltransferase 17 (ZDHHC17). The candidate genes are enriched in several Gene Ontology categories, such as dynein complex and synaptic membrane. Candidate genes and pathways identified in this study provide biological insight into TD etiology and potential targets for future studies.
UR - http://www.scopus.com/inward/record.url?scp=85104282852&partnerID=8YFLogxK
U2 - 10.1038/s41380-021-01094-1
DO - 10.1038/s41380-021-01094-1
M3 - Article
C2 - 33837273
AN - SCOPUS:85104282852
SN - 1359-4184
VL - 26
SP - 6937
EP - 6951
JO - Molecular Psychiatry
JF - Molecular Psychiatry
IS - 11
ER -